Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Eterna Therapeutics ( (ERNA) ).
Ernexa Therapeutics Inc. completed the second closing of its private placement on June 9, 2025, issuing a total of 47,717,087 shares of common stock and 9,332,000 pre-funded warrants, raising approximately $6.0 million in gross proceeds. The company plans to use the funds for general working capital and debt repayment. Additionally, Ernexa is working to regain compliance with Nasdaq’s listing requirements by meeting the Stockholders’ Equity Standard, following a notice received in January 2025 regarding its Market Value of Listed Securities.
More about Eterna Therapeutics
Average Trading Volume: 270,681
Technical Sentiment Signal: Strong Sell
Current Market Cap: $11.23M
See more insights into ERNA stock on TipRanks’ Stock Analysis page.